U.S. Residential REITs Stock News

NYSE:BWXT
NYSE:BWXTAerospace & Defense

How Investors May Respond To BWX Technologies (BWXT) Raised 2026 Outlook And Nuclear Enrichment Push

In early August 2026, BWX Technologies, Inc. reported higher second-quarter and first-half sales and net income, raised its full-year 2026 revenue outlook to approximately US$3.80 billion, and its board declared a quarterly dividend of US$0.27 per share payable on September 4, 2026. The company is also accelerating work on uranium centrifuge technology with the National Nuclear Security Administration, aiming to support a potential large U.S. enrichment buildout across multiple fuel grades...
NYSE:TAP
NYSE:TAPBeverage

Molson Coors Beverage (TAP) Could Be 6% Undervalued Following Q2 Results And Deal Plans

Molson Coors Beverage (TAP) has come into focus after management outlined fresh acquisition plans alongside its second quarter 2026 results, pairing new deal ambitions with ongoing dividends and a sizable share repurchase program. See our latest analysis for Molson Coors Beverage. The latest acquisition talk and Q2 2026 earnings sit against a mixed share price picture for Molson Coors Beverage. The stock has a 1 month share price return of 10.72% and a 90 day share price return of 4.91%, yet...
NYSE:ESS
NYSE:ESSResidential REITs

Will Essex’s Buyback Push and Softer Earnings Shift Essex Property Trust's (ESS) Value-Creation Narrative?

In late July 2026, Essex Property Trust reported higher year-on-year second-quarter revenue but a sharp drop in net income, slightly lowered its full-year 2026 net income guidance, and completed a US$259.25 million buyback while authorizing a new US$500 million share repurchase program alongside ongoing acquisition plans. The combination of upgraded same-property revenue and core FFO guidance with an expanded buyback authorization highlights management’s emphasis on per-share value creation...
NasdaqGM:IOVA
NasdaqGM:IOVABiotechs

Iovance Biotherapeutics (IOVA) Stock Looks Fairly Valued Despite 222% Returns

Iovance Biotherapeutics stock has delivered a striking 221.8% return over the past year, yet the latest valuation checks suggest the shares now look closer to fairly priced than clearly cheap. That mix of strong momentum and a mixed valuation read is what investors are trying to make sense of today. Iovance Biotherapeutics is up 221.8% over the last year, which puts recent buyers in a strong position and raises the bar for what needs to go right next. Strong recent revenue traction from its...
NYSEAM:CMCL
NYSEAM:CMCLMetals and Mining

Caledonia Mining (CMCL) Is Up 15.6% After Strong Q2 2026 Earnings and Profitability Gains

Caledonia Mining Corporation Plc has released its Q2 2026 results, reporting sales of US$75.91 million and net income of US$23.81 million, with basic and diluted earnings per share from continuing operations of US$1.36, all higher than the same period last year. The stronger second-quarter earnings, alongside higher sales and improved profitability over both the quarterly and six‑month periods, point to operational efficiency gains that may be important for how investors assess Caledonia’s...
NYSE:ORCL
NYSE:ORCLSoftware

Does Oracle’s Gemini-Fueled Government Deals Deepen Its AI Moat For ORCL’s Enterprise Platform?

In late July and early August 2026, Oracle Corporation and its partners announced a series of deals, including an expanded collaboration with Google Cloud to bring Gemini AI models into Oracle’s enterprise applications and new Oracle Health and Oracle Fusion HCM projects with Baycrest Hospital and CACI International for major public-sector modernization efforts. Together, these agreements highlight how Oracle is embedding external AI models and its own cloud software into large,...
NasdaqGS:FOXA
NasdaqGS:FOXAMedia

Fox (FOXA) On Earnings And Dividend News Is The Undervalued Narrative Back In Play

Fox (FOXA) drew fresh investor attention on 6 August 2026 after reporting fourth quarter and full year earnings, alongside a higher semi annual dividend and new data partnerships in its advertising business. See our latest analysis for Fox. Fox's earnings release, dividend increase and expanded iSpot partnership come after a mixed share price run, with a 1 month share price return of 18.31% but a year to date share price decline of 13.19%. The 3 year total shareholder return of 96.52%...
NYSE:GPI
NYSE:GPISpecialty Retail

Group 1 Automotive (GPI) Stock Could Be Cheap After A Sharp Pullback

Group 1 Automotive stock has given investors a solid 57.1% total return over the past five years, yet the shares are currently down sharply over the past year and still screen as cheap on several valuation checks. That mix of long term gains, recent weakness and a strong value score is what many investors are now trying to make sense of. Over five years, Group 1 Automotive has returned 57.1%, which points to meaningful long term value creation despite recent share price pressure. The planned...
NYSE:GIC
NYSE:GICTrade Distributors

Global Industrial (GIC) Is Up 7.4% After Strong Q2, Dividend Payout And M&A Push - Has The Bull Case Changed?

In early August 2026, Global Industrial Company reported higher second-quarter and six-month sales and earnings, continued share repurchases totaling 1,132,887 shares since 2018 for US$24.59 million, and declared a US$0.28 per-share cash dividend payable on August 24, 2026. Management also highlighted an active pipeline of potential acquisitions aimed at accelerating go-to-market execution, signaling a stronger emphasis on growth through M&A alongside ongoing capital returns. Next, we’ll...
NYSE:TGT
NYSE:TGTConsumer Retailing

Target (TGT) Debuts PiiPER At Target, Is The Stock Above Fair Value?

PiiPER’s debut baking line is arriving in Target (TGT) stores, alongside upcoming limited time frosting flavors planned for fall. For investors, this product placement highlights how Target uses specialty brands to refresh traffic sensitive categories. See our latest analysis for Target. These new food and baking launches come as Target’s share price has shown strong momentum, with a 30-day share price return of 10.77% and a year-to-date share price return of 48.94%. The 1-year total...
NYSE:AM
NYSE:AMOil and Gas

Antero Midstream (AM) Draws Fresh Attention As Record EBITDA And Pipeline Plans Test Valuation

Antero Midstream (AM) is back in focus after Q2 2026 results, record EBITDA tied to higher gathering volumes, and the launch of its Eastside Express pipeline project, along with debt reduction and completed share repurchases. See our latest analysis for Antero Midstream. Antero Midstream’s share price has eased in the short term, with a 1-day share price return of a 1.02% decline and a 30-day share price return of a 4.53% decline. However, the year-to-date share price return of 18.56% and...
NYSE:COR
NYSE:CORHealthcare

Cencora (COR) Posts Strong Q3 Earnings, Is The 9% Upside Enough?

Cencora (COR) drew investor attention after reporting third quarter 2026 results, highlighting higher sales, net income and earnings per share, along with ongoing share repurchases and a fresh quarterly dividend declaration. See our latest analysis for Cencora. Cencora's recent earnings, dividend declaration and larger revolving credit facility sit against a mixed share price picture, with the stock at US$320.46 and showing a 22.81% 90 day share price return but a decline of 5.43% year to...
NYSE:ARW
NYSE:ARWElectronic

Arrow Electronics (ARW) Stock May Be Overvalued As Its 80% Run Continues

Arrow Electronics has delivered a strong run so far this year, yet the valuation signals are split. The Discounted Cash Flow (DCF) intrinsic value estimate points to a premium to current fundamentals, while earnings-based multiples suggest the stock still screens as undervalued. Arrow Electronics is up about 80% year to date, which puts extra focus on whether recent enthusiasm matches the underlying cash flow profile. Expectations around the company’s ability to sustain cash generation from...
NYSE:ATO
NYSE:ATOGas Utilities

What Atmos Energy (ATO)'s Earnings Beat, Guidance Reaffirmation and Leadership Moves Mean For Shareholders

In early August 2026, Atmos Energy reported higher third-quarter and nine‑month results, reaffirmed its fiscal 2026 earnings guidance of US$8.40–US$8.50 per diluted share, extended its 171st consecutive quarterly dividend at US$1.00 per share, and announced upcoming leadership and board changes, including the planned 2027 retirement of Senior Vice President of Utility Operations John S. McDill. The appointment of long‑time insider Jeff D. Martinez to lead Utility Operations and the addition...
NasdaqGS:PGEN
NasdaqGS:PGENBiotechs

AppLovin Stock Leads 3 Fast Growing Insider Backed Picks To Watch

With US Treasury yields under pressure after softer jobs data, growth stocks with genuine earnings potential suddenly look more interesting. Lower rate hike expectations can make future cash flows from fast growing companies more valuable in investors’ models. That creates a window in which Fast Growing Stocks With High Insider Ownership can stand out. This article highlights three stocks from the screener that combine rapid growth with committed insider backing. The three stocks below are...
NYSE:VST
NYSE:VSTRenewable Energy

Vistra Stock Leads Utility Picks For Grid Reliability And AI Power Demand

When the recent solar eclipse dimmed panels across Great Britain and Europe just as a heatwave pushed air conditioners into overdrive, the spotlight swung back to traditional energy utilities and power generators. Sudden pressure on grids can create winners and laggards, and that is where investor opportunity often hides. This article walks through 3 stocks exposed to these conditions and explains why some investors are paying close attention right now. The 3 stocks below are only a starting...
NasdaqGS:NBIX
NasdaqGS:NBIXBiotechs

Is Neurocrine Biosciences (NBIX) Fully Valued As It Enters Phase 1 Obesity Testing?

Neurocrine Biosciences (NBIX) has drawn fresh attention after announcing a Phase 1 first in human study of NBIP 1968, a triple agonist candidate aimed at obesity treatment and intended for once weekly subcutaneous dosing. See our latest analysis for Neurocrine Biosciences. The Phase 1 obesity study comes on the heels of Neurocrine Biosciences reporting higher second quarter and half year revenue and earnings for 2026, as well as a recent US$742m shelf registration related to an employee stock...
NYSE:EPAM
NYSE:EPAMIT

EPAM Systems (EPAM) Is Down 9.2% After Strong Q2, AI Traction And Large Buyback Completion

In early August 2026, EPAM Systems reported second-quarter 2026 results showing higher sales and net income year-on-year, confirmed full-year guidance, completed a US$632.49 million share repurchase program, and filed new shelf registrations for employee stock offerings. EPAM also highlighted accelerating traction in its AI-native business and its Advanced Partner role in the OpenAI Partner Network, underlining how AI-related services are becoming a more material contributor to its...
NasdaqGS:LIVN
NasdaqGS:LIVNMedical Equipment

LivaNova (LIVN) Is Down 7.6% After Swinging Back To Profitability In Q2 2026 - What's Changed

In August 2026, LivaNova PLC reported second-quarter 2026 sales of US$390.59 million and net income of US$108.57 million, with basic earnings per share from continuing operations rising to US$1.98. For the first half of 2026, the company’s turnaround was underscored by US$752.85 million in sales and a shift from a very large prior-year loss to net income of US$130.86 million. With this sharp improvement in profitability, we’ll now explore how LivaNova’s stronger earnings profile may...
NasdaqGS:SHOP
NasdaqGS:SHOPIT

Shopify (SHOP) Stock Could Be 30% Overvalued Following Strong Q2 AI Growth

Shopify stock has delivered a very strong 170.8% return over the past three years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares trading at a premium rather than on sale. The 170.8% three year return highlights how much optimism has already been priced into Shopify, which raises the bar for what future performance needs to justify. Recent enthusiasm around Shopify's AI driven commerce tools can support higher growth...
NYSE:GEO
NYSE:GEOCommercial Services

GEO Group (GEO) Lifts Guidance On ICE Growth, Is It Still Undervalued?

GEO Group (GEO) is back in focus after reporting second quarter 2026 results that showed higher revenue and net income, updated full year guidance, and new activity around ICE contracts and detention capacity. See our latest analysis for GEO Group. GEO Group’s latest earnings, buyback activity and new ICE contracts have coincided with strong momentum, with a 90 day share price return of 43.34%, a year to date share price return of 92.66% and a 3 year total shareholder return above 3x. If GEO...
NYSE:CMC
NYSE:CMCMetals and Mining

Why Commercial Metals (CMC) Is Up 7.0% After Expanding Buybacks And Targeting Early-Stage Construction Acquisitions

On August 5, 2026, Commercial Metals Company (NYSE:CMC) increased its share repurchase authorization by US$600 million to US$1.45 billion and outlined plans to pursue U.S.-focused, early-stage construction acquisitions that complement its existing capabilities while preserving balance sheet strength. The combination of a larger buyback program and targeted M&A aimed at expanding its early-stage construction footprint could meaningfully influence how investors view Commercial Metals’ capital...
NYSE:AI
NYSE:AISoftware

Is C3.ai (AI) Fully Valued On Its Forrester Leader Recognition?

C3.ai (AI) stock is back in focus after Forrester Research named the company a Leader in its Q3 2026 AI platforms report, highlighting the C3 Agentic AI Platform and positive customer feedback. See our latest analysis for C3.ai. The Forrester recognition arrives during a short burst of momentum for C3.ai, with a 1-month share price return of 14.19% and a 90-day share price return of 16.27%. However, the year-to-date share price is still down 25.67% and the 1-year total shareholder return has...
NasdaqGS:CLBT
NasdaqGS:CLBTSoftware

3 Stocks That May Be Trading Up To 15.1% Below Estimated Intrinsic Value

Over the last 7 days, the United States market has risen by 2.7%, contributing to a substantial 21% increase over the past year. As earnings are forecast to grow by 17% annually, identifying stocks that are trading below their estimated intrinsic value could offer potential opportunities for investors seeking to capitalize on undervalued assets in this thriving market environment.